Table 3 Clinical Characteristics of Lung Cancer Patients with MPC
Clinical Feature | Cases | Proportion (%) | Clinical Feature | Cases | Proportion (%) | ||
|---|---|---|---|---|---|---|---|
Age | < 60 years | 26 | 29.21% | PS Score | 0–1 | 68 | 76.40% |
≥ 60 years | 63 | 60.79% | ≥ 2 | 4 | 4.50% | ||
Pathological Type | Squamous | 13 | 14.61% | Unclear | 17 | 19.10% | |
Adenocarcinoma | 63 | 70.79% | Surgical History | Yes | 59 | 66.29% | |
Adenosquamous | 2 | 2.25% | No | 26 | 25.84% | ||
Small Cell | 5 | 5.62% | Unclear | 4 | 7.87% | ||
NSCLC-NOS | 6 | 6.74% | Molecular Abnormality | Yes | 32 | 35.96% | |
Clinical Stage | Stage I | 39 | 43.82% | No | 6 | 6.74% | |
Stage II | 5 | 5.62% | Unclear | 51 | 57.30% | ||
Stage III | 12 | 13.48% | Hematological Malignancy Occurred First | Yes | 59 | 66.29% | |
Stage IV | 16 | 17.98% | Lung Cancer Occurred First | Yes | 30 | 33.70% | |
Unclear | 17 | 19.10% | |||||